TRCT
HPTX

Tower Research Capital (TRC)’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-530
Closed -$24K – 5636
2015
Q1 		$24K Sell
530
-2,066
-80% -$61.8K ﹤0.01% 2125
2014
Q4 		$62K Buy
+2,596
New +$58.5K 0.01% 926
2014
Q2 		– Sell
-845
Closed -$22K – 5221
2014
Q1 		$22K Sell
845
-1,552
-65% -$42K ﹤0.01% 1810
2013
Q4 		$48K Buy
2,397
+1,296
+118% +$30.5K 0.01% 1432
2013
Q3 		$29K Sell
1,101
-4,325
-80% -$108K ﹤0.01% 2415
2013
Q2 		$119K Buy
+5,426
New +$119K 0.01% 434

Tower Research Capital (TRC)'s HPTX Position: Q2 2015 in Review

Tower Research Capital (TRC) sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 530 shares — an estimated $24K sold.

Tower Research Capital (TRC) first reported a position in HPTX in Q2 2013 and held it in 6 quarters. The position peaked at $119K in Q2 2013. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Tower Research Capital (TRC) reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 530 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $24K.
  • Tower Research Capital (TRC) first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • Tower Research Capital (TRC)'s HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $119K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.